European Working Group on SARS-CoV-2: Current understanding, unknowns, and recommendations on the neurological complications of COVID-19

Crook, Harry, Ramirez, Alfredo, Hosseini, Akram, Vavougyios, Georgios, Lehmann, Clara, Bruchfeld, Judith, Schneider, Anja, D'Avossa, Giovanni, Lo Re, Vincenzina, Salmoiraghi, Alberto, Mukaetova-Ladinska, Elizabeta, Katshu, Mohammad, Boneschi, Filippo M., Håkansson, Krister, Geerlings, Mirjam, Pracht, Elisabeth, Ruiz, Agustín, Jansen, Jacobus F.A., Snyder, Heather, Kivipelto, Miia and Edison, Paul 2023. European Working Group on SARS-CoV-2: Current understanding, unknowns, and recommendations on the neurological complications of COVID-19. Brain Connectivity , pp. 178-210. 10.1089/brain.2022.0058

Full text not available from this repository.

Abstract

Background: The emergence of COVID-19 was rapidly followed by infection and the deaths of millions of people across the globe. With much of the research and scientific advancement rightly focused on reducing the burden of severe and critical acute COVID-19 infection, the long-term effects endured by those who survived the acute infection has been previously overlooked. Now, an appreciation for the post-COVID-19 condition, including its neurological manifestations, is growing, although there remain many unknowns regarding the etiology and risk factors of the condition, as well as how to effectively diagnose and treat it. Methods: Here, drawing upon the experiences and expertise of the clinicians and academics of the European working group on COVID-19, we have reviewed the current literature to provide a comprehensive overview of the neurological sequalae of the post-COVID-19 condition. Results: In this review, we provide a summary of the neurological symptoms associated with the post-COVID-19 condition, before discussing the possible mechanisms which may underly and manifest these symptoms. Following this, we explore the risk factors for developing neurological symptoms as a result of COVID-19 and the post-COVID-19 condition, as well as how COVID-19 infection may itself be a risk factor for the development of neurological disease in the future. Lastly, we evaluate how the post-COVID condition could be accurately diagnosed and effectively treated, including examples of the current guidelines, clinical outcomes, and tools that have been developed to aid in this process, as well as addressing the protection provided by COVID-19 vaccines against the post-COVID-19 condition. Conclusions: Overall, this review provides a comprehensive overview of the neurological sequalae of the post-COVID-19 condition.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Mary Ann Liebert
ISSN:	2158-0014
Date of Acceptance:	31 January 2023
Last Modified:	28 Jul 2023 08:55
URI:	https://orca.cardiff.ac.uk/id/eprint/158891

Actions (repository staff only)

Edit Item